Moberg Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	236.2	293.29	60.56	125.55	102.66	19.29
Cash & Short-Term Investments	236.2	293.29	60.56	125.55	102.66	19.29
Cash Growth	-23.55%	384.33%	-51.77%	22.30%	432.28%	-46.83%
Accounts Receivable	8.22	0.17	-	0.38	0.47	-
Other Receivables	-	0.64	0.79	1.06	0.66	2.16
Receivables	8.22	0.8	0.79	1.44	1.14	2.16
Inventory	5.05	4.3	7.12	-	-	-
Prepaid Expenses	-	1.58	0.9	0.72	0.75	0.85
Other Current Assets	-	0.14	0.14	0.06	0.12	144.52
Total Current Assets	249.46	300.11	69.49	127.76	104.66	166.81
Property, Plant & Equipment	3.22	4.42	4.94	5.98	4.52	7.1
Long-Term Deferred Tax Assets	98.38	95.78	28.08	22.58	14.67	10.93
Long-Term Deferred Charges	342.6	305.77	532.22	408.1	327.04	295.73
Total Assets	693.66	706.09	634.73	564.42	450.89	480.58
Accounts Payable	-	4.16	6.77	17.11	5.31	2.95
Accrued Expenses	-	10.67	12.5	7.56	7.45	8.73
Current Portion of Leases	1.66	1.6	1.27	2.12	2.7	2.64
Other Current Liabilities	13.8	0.29	-	-	0.09	65.87
Total Current Liabilities	15.46	16.72	20.54	26.79	15.54	80.18
Long-Term Leases	1.3	2.55	3.47	3.99	1.24	4.75
Other Long-Term Liabilities	-	-	-	0.07	0.07	0.07
Total Liabilities	16.75	19.27	24.01	30.84	16.84	85
Common Stock	46.69	46.69	27.96	9.83	4.41	2.09
Additional Paid-In Capital	1,238	1,234	921.3	841.2	731.38	693.28
Retained Earnings	-608.12	-593.64	-338.53	-317.44	-301.73	-309.22
Comprehensive Income & Other	-	-	-	-	-	1.73
Total Common Equity	676.9	686.82	610.73	533.58	434.05	387.87
Minority Interest	-	-	-	-	-	7.71
Shareholders' Equity	676.9	686.82	610.73	533.58	434.05	395.58
Total Liabilities & Equity	693.66	706.09	634.73	564.42	450.89	480.58
Total Debt	2.95	4.14	4.74	6.11	3.93	7.4
Net Cash (Debt)	233.24	289.15	55.82	119.45	98.72	11.89
Net Cash Growth	-23.60%	418.02%	-53.27%	20.99%	730.24%	-47.89%
Net Cash Per Share	4.99	7.64	3.52	15.74	22.94	6.28
Filing Date Shares Outstanding	47	46.69	27.96	9.83	4.4	1.99
Total Common Shares Outstanding	47	46.69	27.96	9.83	4.4	1.99
Working Capital	234.01	283.39	48.95	100.97	89.12	86.63
Book Value Per Share	14.40	14.71	21.84	54.30	98.54	195.26
Tangible Book Value	676.9	686.82	610.73	533.58	434.05	387.87
Tangible Book Value Per Share	14.40	14.71	21.84	54.30	98.54	195.26

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.